AP9801350A0 - Parasitical formulations. - Google Patents

Parasitical formulations.

Info

Publication number
AP9801350A0
AP9801350A0 APAP/P/1998/001350A AP9801350A AP9801350A0 AP 9801350 A0 AP9801350 A0 AP 9801350A0 AP 9801350 A AP9801350 A AP 9801350A AP 9801350 A0 AP9801350 A0 AP 9801350A0
Authority
AP
ARIPO
Prior art keywords
parasitical
formulations
administer
convenient
protection against
Prior art date
Application number
APAP/P/1998/001350A
Other languages
English (en)
Inventor
Hiep Huatan
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of AP9801350A0 publication Critical patent/AP9801350A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
APAP/P/1998/001350A 1997-09-23 1998-09-17 Parasitical formulations. AP9801350A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
AP9801350A0 true AP9801350A0 (en) 2000-03-17

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001350A AP9801350A0 (en) 1997-09-23 1998-09-17 Parasitical formulations.

Country Status (13)

Country Link
EP (1) EP1014970A1 (fr)
JP (1) JP2001517622A (fr)
AP (1) AP9801350A0 (fr)
AR (1) AR013509A1 (fr)
AU (1) AU9742298A (fr)
BR (1) BR9812385A (fr)
CA (1) CA2304283A1 (fr)
GT (1) GT199800149A (fr)
MA (1) MA24655A1 (fr)
PA (1) PA8459501A1 (fr)
PE (1) PE117199A1 (fr)
TN (1) TNSN98175A1 (fr)
WO (1) WO1999015166A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
WO2018226512A1 (fr) * 2017-06-06 2018-12-13 Merck Sharp & Dohme Corp. Implant à action prolongée pour le traitement de maladies infectieuses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (fr) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectine comme agents pour promotion de la croissance
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
PA8459501A1 (es) 2000-05-24
GT199800149A (es) 2000-03-15
PE117199A1 (es) 1999-11-20
AR013509A1 (es) 2000-12-27
TNSN98175A1 (fr) 2005-03-15
MA24655A1 (fr) 1999-04-01
JP2001517622A (ja) 2001-10-09
WO1999015166A1 (fr) 1999-04-01
AU9742298A (en) 1999-04-12
BR9812385A (pt) 2000-09-12
EP1014970A1 (fr) 2000-07-05
CA2304283A1 (fr) 1999-04-01

Similar Documents

Publication Publication Date Title
WO2000041681A3 (fr) FORMULATIONS DE MEDICAMENTS CONTENANT UN OPIOIDE ET UN α-AGONISTE
MY118151A (en) Pharmaceutical formulations containing voriconazole.
AU2000279625A1 (en) Blood mmp-3 level-lowering agent containing il-6 antgonist as the active ingredient
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
AU1276501A (en) Active ingredient combination having insecticidal and acaricidal characteristics
BG106586A (en) Pyrazolopyramidines as therapeutic agents
IL153297A0 (en) Compounds and compositions for delivering active agents
AU2001295017A1 (en) Solid dose nanoparticulate compositions
HK1024182A1 (en) Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
ZA200003121B (en) Flash-melt oral dose formulations.
CA2339765A1 (fr) Composes et compositions pour l'administration de principes actifs
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
GB0025173D0 (en) Therapeutic agents
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
IL146025A0 (en) Improved pharmaceutical formulations comprising at least one hiv protease inhibiting compound
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
AP9801350A0 (en) Parasitical formulations.
WO2002015959A3 (fr) Composes et compositions permettant de distribuer des agents actifs
NO994431L (no) Ny formulering
GB9907571D0 (en) Compounds
AU2002210407A1 (en) Therapeutic vaccine formulations containing chitosan
ZA200201807B (en) Active ingredient combinations having insecticidal and acaricidal properties.